This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

10 Best Revenue Growth Stocks for 2012

NEW YORK ( TheStreet) - Analysts often use a company's current and projected growth rate as a metric to determine the stock's future price. With a potential for robust revenue gains in 2012 or the upcoming quarters, these stocks should be on every investor's radar. In addition, some of these have estimated strong bottom line gains.

Based on average estimates of analysts polled by Bloomberg, these 10 stocks have potential upsides ranging from 8% to 74%, with average buy and average hold guidance of 70% and 27%, respectively.

10. Ecolab (ECL - Get Report) develops and markets products and services for the hospitality, food service, health care and industrial markets. It provides cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services.

For the third quarter of fiscal year 2011, ECL reported revenue of $1.7 billion, up 11%. Net income attributable to shareholders rose 13% to $177 million and adjusted diluted earnings per share increased 14% to 75 cents. International sales increased 18% and operating income improved by 23%.

Follow TheStreet on Twitter and become a fan on Facebook.

The company expects adjusted earnings per share for fiscal 2011, excluding the impact of the Nalco merger, to be in the range of $2.53 to $2.55, growing 13% to 14% from 2010.

Earlier this month, ECL acquired Esoform, an independent Italian health care manufacturer focused on infection prevention and personal care.

The company has increased its quarterly cash dividend by 14% to 20 cents per common share, payable Jan. 17, 2012.

Of the 18 analysts covering the stock, 67% recommend buying and 28% suggest a hold. The stock's average 12-month price target is $61.92, about 8.8% higher than the current price, a Bloomberg consensus shows.

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ANR $1.20 0.42%
AMZN $383.99 -0.43%
CRM $67.95 -0.74%
CTSH $62.81 -0.17%
ECL $115.16 -0.69%


DOW 18,214.68 -73.95 -0.40%
S&P 500 2,108.73 -8.66 -0.41%
NASDAQ 4,985.0430 -23.0530 -0.46%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs